Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate safety of experimental medication BMS-986242 and Nivolumab in patients with advanced cancers.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bristol-Myers Squibb
NCT05468034 · Breast Cancer, Indolent Metastatic Breast Cancer
NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more
NCT06204094 · Locally Advanced Rectal Cancer
NCT05398783 · Metabolic Disorders, Cancer, and more
NCT03137095 · Cancer Related Cognitive Difficulties, Breast Cancer Female
University Of Alabama At Birmingham
Birmingham, Alabama
Hoag Memorial Hospital Presbyterian
Los Angeles, California
USC Norris Comprehensive Cancer Center
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions